🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Association of Soluble Interleukin-2 Receptor α and Tumour Necrosis Factor Receptor 1 with Heart Failure: The Multi-Ethnic Study of Atherosclerosis

ESC Heart Failure(2020)10.1002/ehf2.12623Source: DataRank Database

Association of Soluble Interleukin-2 Receptor α and Tumour Necrosis Factor Receptor 1 with Heart Failure: The Multi-Ethnic Study of Atherosclerosis is a research paper published in ESC Heart Failure (2020). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (51 grants)Impact (FWCI 1.79)OA: goldTopics (58)IDs (PubMed, PMC, OpenAlex)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Vinithra Varadarajan ORCID,Bharath Ambale‐Venkatesh ORCID,Zahra Meyghani,Mohammad R. Ostovaneh ORCID,Peter Durda ORCID

Live enrichment

PubMed:32155316 PMC:PMC7160474 OpenAlex:https://openalex.org/W3012467235

National Heart, Lung, and Blood Institute

Grant: 75N92020D00001

National Heart, Lung, and Blood Institute

Grant: HHSN268201500003I

National Heart, Lung, and Blood Institute

Grant: N01-HC-95159

National Heart, Lung, and Blood Institute

Grant: 75N92020D00005

National Heart, Lung, and Blood Institute

Grant: N01-HC-95160

National Heart, Lung, and Blood Institute

Grant: 75N92020D00002

National Heart, Lung, and Blood Institute

Grant: N01-HC-95161

National Heart, Lung, and Blood Institute

Grant: 75N92020D00003

National Heart, Lung, and Blood Institute

Grant: N01-HC-95162

National Heart, Lung, and Blood Institute

Grant: 75N92020D00006

National Heart, Lung, and Blood Institute

Grant: N01-HC-95163

National Heart, Lung, and Blood Institute

Grant: 75N92020D00004

National Heart, Lung, and Blood Institute

Grant: N01-HC-95164

National Heart, Lung, and Blood Institute

Grant: 75N92020D00007

National Heart, Lung, and Blood Institute

Grant: N01-HC-95165

National Heart, Lung, and Blood Institute

Grant: N01-HC-95166

National Heart, Lung, and Blood Institute

Grant: N01-HC-95167

National Heart, Lung, and Blood Institute

Grant: N01-HC-95168

National Heart, Lung, and Blood Institute

Grant: N01-HC-95169

NCATS

Grant: UL1-TR-000040

NCATS

Grant: UL1-TR-001079

NCATS

Grant: UL1-TR-001420

National Center for Advancing Translational Sciences

Grant: UL1‐TR‐000040

National Center for Advancing Translational Sciences

Grant: UL1‐TR‐001079

National Center for Advancing Translational Sciences

Grant: UL1‐TR‐001420

NHLBI NIH HHS

Grant: N01 HC095163

NHLBI NIH HHS

Grant: N01 HC095162

NHLBI NIH HHS

Grant: N01 HC095167

NHLBI NIH HHS

Grant: N01 HC095169

NHLBI NIH HHS

Grant: HHSN268201500003C

NHLBI NIH HHS

Grant: N01 HC095160

NHLBI NIH HHS

Grant: N01 HC095161

NHLBI NIH HHS

Grant: N01 HC095159

NHLBI NIH HHS

Grant: N01 HC095164

NHLBI NIH HHS

Grant: N01 HC095165

NHLBI NIH HHS

Grant: N01 HC095168

NHLBI NIH HHS

Grant: N01 HC095166

National Institutes of Health

Grant: N01HC095164-002

SUBCLINICAL CARDIOVASCULAR DISEASE STUDY-FIELD CENTER

National Institutes of Health

Grant: N01HC095162-000

SUBCLINICAL CARDIOVASCULAR DISEASE STUDY-FIELD CENTER

National Institutes of Health

Grant: 3UL1TR001079-02S1

Institute for Clinical and Translational Research

National Institutes of Health

Grant: N01HC095169-004

SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--EBCT READING

National Institutes of Health

Grant: N01HC095165-001

SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--FIELD CENTER

National Institutes of Health

Grant: N01HC095161-000

SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--FIELD CENTER

National Institutes of Health

Grant: N01HC095166-002

SUBCLINICAL CARDIOVASCULAR DISEASE STUDY

National Institutes of Health

Grant: N01HC095160-000

SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--FIELD CENTER

National Institutes of Health

Grant: N01HC095167-000

SUBCLINICAL CARDIOVASCULAR DISEASE STUDY-ULTRASOUND

National Institutes of Health

Grant: 1UL1TR001420-01

Wake forest Clinical and Translational Science Award

National Institutes of Health

Grant: 8UL1TR000040-07

Clinical and Translational Science Award

National Institutes of Health

Grant: N01HC095159-011

SUBCLINICAL CARDIOVASCULAR DISEASE COORDINATING CENTER-268995159

National Institutes of Health

Grant: N01HC095163-000

SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--FIELD CENTER

National Institutes of Health

Grant: N01HC095168-000

SUBCLINICAL CARDIOVASCULAR DISEASE STUDY

FWCI

1.79

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ehf2.12623

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ehf2.12623

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fehf2.12623

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12623

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/ehf2.12623

Fields of Study

Cardiac Fibrosis and RemodelingAdipokines, Inflammation, and Metabolic DiseasesAtherosclerosis and Cardiovascular Diseases03 medical and health sciences0302 clinical medicineAgedAtherosclerosisFemaleHeart FailureHumansIncidenceInterleukin-2 Receptor alpha SubunitMaleMiddle AgedProspective StudiesReceptors, Tumor Necrosis Factor, Type I

MeSH Terms

AgedFemaleHeart FailureHumansMaleMiddle AgedProspective StudiesIncidenceReceptors, Tumor Necrosis Factor, Type IAtherosclerosisInterleukin-2 Receptor alpha Subunit

Keywords

Interquartile rangeMedicineHazard ratioInternal medicinePopulationHeart failureProportional hazards modelCoronary artery diseaseAsymptomaticProspective cohort studyCardiologyConfidence intervalInterleukin-2InflammationTumour Necrosis Factor-αSoluble Cytokine ReceptorsMaleTumour necrosis factor‐αIncidenceInterleukin-2 Receptor alpha SubunitMiddle AgedAtherosclerosisInterleukin‐2Receptors, Tumor Necrosis Factor, Type IRC666-701Original Research ArticlesDiseases of the circulatory (Cardiovascular) systemHumansFemaleProspective StudiesAged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 16: 16. Peace & justiceSDG 0: Good health and well-being

Related Papers (8)

Usefulness of Natriuretic Peptide Levels to Predict Mortality in Adults With Congenital Heart Disease

The American Journal of Cardiology(2010)

OpenAlex related

10.1016/j.amjcard.2009.11.041

Initial experience introducing an enhanced recovery program in congenital cardiac surgery

Journal of Thoracic and Cardiovascular Surgery(2019)

OpenAlex related

10.1016/j.jtcvs.2019.10.049

Efficacy and safety of lung recruitment in pediatric patients with acute lung injury

Pediatric Critical Care Medicine(2010)

OpenAlex related

10.1097/pcc.0b013e3181fe329d

Hemoglobin Levels Across the Pediatric Critical Care Spectrum: A Point Prevalence Study*

Pediatric Critical Care Medicine(2018)

OpenAlex related

10.1097/pcc.0000000000001467

Prognostic value of proadrenomedullin in patients with COVID-19 pneumonia

Frontiers in Medicine(2022)

OpenAlex related

10.3389/fmed.2022.961071

[The relationship between hazard ratio and median survival time].

PubMed(2019)

OpenAlex related

10.3760/cma.j.issn.0253-9624.2019.05.021

Use of Coronary CT Angiography as a Screening Tool for Coronary Artery Disease in Asymptomatic Healthy Individuals or Patients

Journal of the Korean Society of Radiology(2022)

OpenAlex related

10.3348/jksr.2021.0161

059 Secondary progressive MS in the UK: a prospective cohort study

Journal of Neurology Neurosurgery & Psychiatry(2022)

OpenAlex related

10.1136/jnnp-2022-abn.96